Bethany J. Cavanagh's most recent trade in Beam Therapeutics Inc was a trade of 6,287 Common Stock done at an average price of $35 . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 18 Feb 2025 | 6,287 | 37,527 (0%) | 0% | 35 | 220,045 | Common Stock |
Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 02 Jan 2025 | 1,117 | 43,814 (0%) | 0% | 24.7 | 27,568 | Common Stock | |
Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 30 Sep 2024 | 2,500 | 45,220 (0%) | 0% | 0 | Common Stock | ||
Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 30 Sep 2024 | 289 | 44,931 (0%) | 0% | 23.5 | 6,785 | Common Stock | |
Beam Therapeutics Inc | Bethany J. Cavanagh | SVP, Finance and Treasurer | 31 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |